Jake Sattelmair, cofounder and chief executive officer, Wellframe, discusses a new collaboration between Wellframe and Validic with regard to how data and technology will be integrated to help patients and providers manage chronic conditions...
Jake Sattelmair, cofounder and chief executive officer, Wellframe, discusses a new collaboration between Wellframe and Validic with regard to how data and technology will be integrated to help patients and providers manage chronic conditions...
Ramesh Balakrishnan, cochief executive officer and president, UpHealth, and Jamey Edwards, chief executive officer and cofounder, Cloudbreak, discuss how the new partnership between Cloudbreak Health and Thraysis aims to improve the health...
Ramesh Balakrishnan, cochief executive officer and president, UpHealth, and Jamey Edwards, chief executive officer and cofounder, Cloudbreak, discuss how the new partnership between Cloudbreak Health and Thraysis aims to improve the health...
Matt Lambert, MD, chief medical officer, Curation Health, discusses why there is a push among many physicians to move to a more value-based care model over a fee-for-service model, explains how he sees care shifting in the future, and...
Matt Lambert, MD, chief medical officer, Curation Health, discusses why there is a push among many physicians to move to a more value-based care model over a fee-for-service model, explains how he sees care shifting in the future, and...
Nicole Neumarker, EVP, Cotiviti, discusses what health care organizations should know regarding what Amazon is doing to collect, store, process and analyze data, and talks about why the use of AI and the Amazon model could be the answer to...
Nicole Neumarker, EVP, Cotiviti, discusses what health care organizations should know regarding what Amazon is doing to collect, store, process and analyze data, and talks about why the use of AI and the Amazon model could be the answer to...
Ben Zaniello, MD, MPH, chief medical officer, Collective Medical, talks about why real-time data is important in health care, how care has changed from times before the use of this data, and highlights where the future of care is going.
Ben Zaniello, MD, MPH, chief medical officer, Collective Medical, talks about why real-time data is important in health care, how care has changed from times before the use of this data, and highlights where the future of care is going.
Matt Dickson, vice president of product and strategy and general manager of communication solutions at Stericycle, highlights the benefits of patient scheduling technology, explains how it has helped during the pandemic, and offers tips to...
Matt Dickson, vice president of product and strategy and general manager of communication solutions at Stericycle, highlights the benefits of patient scheduling technology, explains how it has helped during the pandemic, and offers tips to...
Matthew Michela, CEO, Life Image, explains why cloud adoption is essential for data sharing during the current pandemic and beyond, how organizations can prepare for ONC compliance deadlines, and provides advice for organizations who are...
Matthew Michela, CEO, Life Image, explains why cloud adoption is essential for data sharing during the current pandemic and beyond, how organizations can prepare for ONC compliance deadlines, and provides advice for organizations who are...
Assaf Halevy, founder and CEO, 2bPrecise, and Jacob Johnson, MD, president, San Francisco Otolaryngology Medical Group, explain how pharmacogenomics help physicians prescribe patients the correct medications at the right time, what this means...
Assaf Halevy, founder and CEO, 2bPrecise, and Jacob Johnson, MD, president, San Francisco Otolaryngology Medical Group, explain how pharmacogenomics help physicians prescribe patients the correct medications at the right time, what this means...
Steve Wigginton, CEO, NovuHealth, and Jeff Fritz, CEO, Revel, discuss their recent merger, highlighting how it will impact care and system flows for the more than 50 health care organizations these companies currently work with, including...
Steve Wigginton, CEO, NovuHealth, and Jeff Fritz, CEO, Revel, discuss their recent merger, highlighting how it will impact care and system flows for the more than 50 health care organizations these companies currently work with, including...
David Smith, MTP project executive, AVIA, discusses the results of the Medicaid Transformation Project Phase One Report, provides examples of tools needed to continue to drive innovation that address the unmet needs of vulnerable populations,...
David Smith, MTP project executive, AVIA, discusses the results of the Medicaid Transformation Project Phase One Report, provides examples of tools needed to continue to drive innovation that address the unmet needs of vulnerable populations,...
Roy Moore outlines how a rapidly expanding atopic dermatitis pipeline is intensifying competition, reshaping payer strategies, and raising the bar for new therapies.
Roy Moore outlines how a rapidly expanding atopic dermatitis pipeline is intensifying competition, reshaping payer strategies, and raising the bar for new therapies.
Roy Moore of Clarivate’s market access team discussed the evolving migraine treatment landscape, highlighting the maturation of the acute and prophylactic markets, the emergence of new therapies such as triptan-COX-2 combinations, gepants,...
Roy Moore of Clarivate’s market access team discussed the evolving migraine treatment landscape, highlighting the maturation of the acute and prophylactic markets, the emergence of new therapies such as triptan-COX-2 combinations, gepants,...
Roy Moore, a market access expert, discusses the evolving asthma drug pipeline, highlighting upcoming therapies—including Breztri, depemokimab, and masitinib—their potential to improve adherence and outcomes, payer considerations around cost...
Roy Moore, a market access expert, discusses the evolving asthma drug pipeline, highlighting upcoming therapies—including Breztri, depemokimab, and masitinib—their potential to improve adherence and outcomes, payer considerations around cost...
In this edition of Pipeline Projections, Roy Moore breaks down the rapidly evolving landscape of multiple sclerosis treatments—highlighting the shift from injectables to orals, the rise of monoclonal antibodies, and the promise of innovative...
In this edition of Pipeline Projections, Roy Moore breaks down the rapidly evolving landscape of multiple sclerosis treatments—highlighting the shift from injectables to orals, the rise of monoclonal antibodies, and the promise of innovative...
In this episode of Pipeline Projections, Roy Moore—Senior Healthcare Research & Data Analyst at Clarivate—discusses the expanding biosimilar pipeline for autoimmune diseases. He highlights recent FDA approvals, formulary and pricing...
In this episode of Pipeline Projections, Roy Moore—Senior Healthcare Research & Data Analyst at Clarivate—discusses the expanding biosimilar pipeline for autoimmune diseases. He highlights recent FDA approvals, formulary and pricing...
The US Department of Health and Human Services (HHS) has formally scrapped its 340B Rebate Model Pilot Program following a series of court rulings that blocked its implementation—signaling a significant pause in one of the most closely...
The US Department of Health and Human Services (HHS) has formally scrapped its 340B Rebate Model Pilot Program following a series of court rulings that blocked its implementation—signaling a significant pause in one of the most closely...
On February 3, 2026, President Donald Trump signed a broad government funding package that includes multi-year extensions for Medicare teleath and hospital-at-home programs, new oversight requirements for pharmacy benefit managers (PBMs), and...
On February 3, 2026, President Donald Trump signed a broad government funding package that includes multi-year extensions for Medicare teleath and hospital-at-home programs, new oversight requirements for pharmacy benefit managers (PBMs), and...
The Senate has done it. After weeks of behind-the-scenes wrangling and last-minute amendments, lawmakers have passed a sprawling tax-and-spending megabill that makes good on a long-standing Republican goal: making the 2017 Trump tax cuts...
The Senate has done it. After weeks of behind-the-scenes wrangling and last-minute amendments, lawmakers have passed a sprawling tax-and-spending megabill that makes good on a long-standing Republican goal: making the 2017 Trump tax cuts...
In Washington, the most consequential policies are often buried in the fine print. One such detail in the Senate Finance Committee’s latest tax and spending proposal would gradually cap provider taxes—a core funding tool states use to pull in...
In Washington, the most consequential policies are often buried in the fine print. One such detail in the Senate Finance Committee’s latest tax and spending proposal would gradually cap provider taxes—a core funding tool states use to pull in...
Over the past few weeks, I’ve been following the progress of the One Big Beautiful Bill Act (OBBBA), which started in the House with sweeping tax reforms and some eye-catching health care proposals. Now, the Senate has released its (highly...
Over the past few weeks, I’ve been following the progress of the One Big Beautiful Bill Act (OBBBA), which started in the House with sweeping tax reforms and some eye-catching health care proposals. Now, the Senate has released its (highly...
With the One Big Beautiful Bill Act (OBBBA) still in the hands of the Senate, much of the national conversation has centered on what this legislation would do to federal coverage programs. But regardless of how the federal process unfolds,...
With the One Big Beautiful Bill Act (OBBBA) still in the hands of the Senate, much of the national conversation has centered on what this legislation would do to federal coverage programs. But regardless of how the federal process unfolds,...
It’s been weeks of headline-grabbing debate over Medicaid work requirements, and the “One Big Beautiful Bill Act” remains in the Senate as they deliberate over several health care provisions. While the Medicaid provisions sparked most of the...
It’s been weeks of headline-grabbing debate over Medicaid work requirements, and the “One Big Beautiful Bill Act” remains in the Senate as they deliberate over several health care provisions. While the Medicaid provisions sparked most of the...
Last week, the House of Representatives narrowly passed the One Big Beautiful Bill Act (HR 1, 119th Congress) by a single vote, sending the sweeping tax and spending reconciliation package, backed by President Trump, to the Senate. With its...
Last week, the House of Representatives narrowly passed the One Big Beautiful Bill Act (HR 1, 119th Congress) by a single vote, sending the sweeping tax and spending reconciliation package, backed by President Trump, to the Senate. With its...
It’s been another eventful week in health policy—a phrase that’s quickly becoming routine. This time, House Republicans advanced a sweeping budget reconciliation bill, designed to implement elements of the March budget resolution, with a...
It’s been another eventful week in health policy—a phrase that’s quickly becoming routine. This time, House Republicans advanced a sweeping budget reconciliation bill, designed to implement elements of the March budget resolution, with a...
It’s been a busy few days for drug pricing policy. While I’d love to dig into the details of both President Trump’s latest executive order and the newest Republican bill that would cut Medicaid spending, we don’t have the time—and this isn’t...
It’s been a busy few days for drug pricing policy. While I’d love to dig into the details of both President Trump’s latest executive order and the newest Republican bill that would cut Medicaid spending, we don’t have the time—and this isn’t...